Roxane Tussiwand

Roxane Tussiwand

Auto-generated profile, based on publicly available information

Roxane Tussiwand

National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2014 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
MGMartin Guilliams
Martin Guilliams
FGFlorent Ginhoux
Florent Ginhoux
CJClaudia Jakubzick
Claudia Jakubzick
SNShalin H. Naik
Shalin H. Naik
Nobuyuki OnaiNobuyuki Onai
Nobuyuki Onai
SYSimon Yona
Simon Yona

5 January 2015 in Nature
Verified
Journal Article
Closed access
PDF file
SNShruti Naik
Shruti Naik
NBNicolas Bouladoux
Nicolas Bouladoux
JLJonathan L. Linehan
Jonathan L. Linehan
SHSeong-Ji Han
Seong-Ji Han
OHOliver J. Harrison
Oliver J. Harrison
YBYasmine Belkaid
Yasmine Belkaid

1 May 2015 in Immunity
Verified
Journal Article
Closed access
RTRoxane Tussiwand
Roxane Tussiwand
BEBart Everts
Bart Everts
GGGary E. Grajales-Reyes
Gary E. Grajales-Reyes
NKNicole M. Kretzer
Nicole M. Kretzer
AIArifumi Iwata
Arifumi Iwata
KMKenneth M. Murphy
Kenneth M. Murphy

20 May 2016 in Annual Review of Immunology
Verified
Journal Article
Closed access
TMTheresa L. Murphy
Theresa L. Murphy
GGGary E. Grajales-Reyes
Gary E. Grajales-Reyes
XWXiaodi Wu
Xiaodi Wu
RTRoxane Tussiwand
Roxane Tussiwand
CBCarlos G. Briseño
Carlos G. Briseño
KMKenneth M. Murphy
Kenneth M. Murphy
The dendritic cells (DCs) of the immune system function in innate and adaptive responses by directing activity of various effector cells rather than serving as effectors themselves. DCs and closely related myeloid lineages share expression of many surface receptors, presenting a challenge in distinguishing their unique in vivo functions. Recent work has taken advantage of unique transcriptional programs to identify and manipulate murine DCs in vivo. This work has assigned several nonredundant in vivo functions to distinct DC lineages, consisting of plasmacytoid DCs and several subsets of classical DCs that promote different immune effector modules in response to pathogens. In parallel, a correspondence between human and murine DC subsets has emerged, underlying structural similarities for the DC lineages between these species. Recent work has begun to unravel the transcriptional circuitry that controls the development and diversification of DCs from common progenitors in the bone marrow.

21 June 2013 in Nature Reviews Immunology
Verified
Journal Article
Closed access
TMTheresa L. Murphy
Theresa L. Murphy
RTRoxane Tussiwand
Roxane Tussiwand
KMKenneth M. Murphy
Kenneth M. Murphy

19 September 2012 in Nature
Verified
Journal Article
Open access
PDF file
RTRoxane Tussiwand
Roxane Tussiwand
WLWan-Ling Lee
Wan-Ling Lee
TMTheresa L. Murphy
Theresa L. Murphy
MMMona Mashayekhi
Mona Mashayekhi
WKWumesh Kc
Wumesh Kc
KMKenneth M. Murphy
Kenneth M. Murphy
The AP1 transcription factor Batf3 is required for homeostatic development of CD8α+ classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for CD8α+ dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-γ. This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection. Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4. Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation. Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.